These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10805163)

  • 1. Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them?
    Eckstein F
    Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):117-21. PubMed ID: 10805163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence confirmation of synthetic phosphorothioate oligodeoxynucleotides using Sanger sequencing reactions in combination with mass spectrometry.
    Lu DD; Chen SH; Zhang W; Liang QD; Wang SQ
    Anal Biochem; 2005 Oct; 345(1):81-9. PubMed ID: 16102718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides.
    Geary RS; Yu RZ; Levin AA
    Curr Opin Investig Drugs; 2001 Apr; 2(4):562-73. PubMed ID: 11566019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards rational design of antisense DNA: molecular modelling of phosphorothioate DNA analogues.
    Jaroszewski JW; Syi JL; Maizel J; Cohen JS
    Anticancer Drug Des; 1992 Jun; 7(3):253-62. PubMed ID: 1610482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of phosphorothioate antisense Bcl-xL oligodeoxynucleotides on apoptosis and thermosensitivity of BcaCD885 cells].
    He YW; Bian L; Liang XH
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):112-4. PubMed ID: 15190790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of antisense oligodeoxynucleotides for suppression of Na+/Ca2+ exchange.
    Schwaller B; Egger M; Lipp P; Niggli E
    Methods Enzymol; 2000; 314():454-76. PubMed ID: 10565032
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of antisense oligodeoxynucleotides for transplantation.
    Stepkowski SM
    Curr Opin Mol Ther; 2000 Jun; 2(3):304-17. PubMed ID: 11249625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of oligo(deoxynucleoside phosphorothioate)s and their diastereomeric composition.
    Wilk A; Stec WJ
    Nucleic Acids Res; 1995 Feb; 23(3):530-4. PubMed ID: 7885850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for higher-order structure formation by the c-myb 18-mer phosphorothioate antisense (codons 2-7) oligodeoxynucleotide: potential relationship to antisense c-myb inhibition.
    Vilenchik M; Benimetsky L; Kolbanovsky A; Miller P; Stein CA
    Antisense Nucleic Acid Drug Dev; 2001 Apr; 11(2):87-97. PubMed ID: 11334144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of terminal phosphorothioates into oligonucleotides.
    Alefelder S; Patel BK; Eckstein F
    Nucleic Acids Res; 1998 Nov; 26(21):4983-8. PubMed ID: 9776763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of phosphorothioate oligodeoxynucleotides to basic fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independent.
    Benimetskaya L; Tonkinson JL; Koziolkiewicz M; Karwowski B; Guga P; Zeltser R; Stec W; Stein CA
    Nucleic Acids Res; 1995 Nov; 23(21):4239-45. PubMed ID: 7501441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemically modified oligonucleotides exhibit decreased immune stimulation in mice.
    Henry S; Stecker K; Brooks D; Monteith D; Conklin B; Bennett CF
    J Pharmacol Exp Ther; 2000 Feb; 292(2):468-79. PubMed ID: 10640282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer solution-filled column for the analysis of antisense phosphorothioates by capillary electrophoresis.
    Chen SH; Tzeng RT
    Electrophoresis; 1999 Mar; 20(3):547-54. PubMed ID: 10217170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation of stable hepadnaviral mRNA cleavage fragments induced by the action of phosphorothioate-modified antisense oligodeoxynucleotides.
    Hasselblatt P; Hockenjos B; Thoma C; Blum HE; Offensperger WB
    Nucleic Acids Res; 2005; 33(1):114-25. PubMed ID: 15640448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Streptococcus mutans with antisense oligodeoxyribonucleotides to gtfB mRNA inhibits GtfB expression and function.
    Guo QY; Xiao G; Li R; Guan SM; Zhu XL; Wu JZ
    FEMS Microbiol Lett; 2006 Nov; 264(1):8-14. PubMed ID: 17020543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase synthesis of stereoregulated oligodeoxyribonucleoside phosphorothioates.
    Oka N; Yamamoto M; Sato T; Wada T
    Nucleic Acids Symp Ser (Oxf); 2006; (50):123-4. PubMed ID: 17150848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propynylated phosphodiester oligonucleotides inhibit ICAM-1 expression in A549 cells on electroporation.
    Meunier L; Monsigny M; Roche AC
    Antisense Nucleic Acid Drug Dev; 2001 Apr; 11(2):117-23. PubMed ID: 11334140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of duck hepatitis B virus DNA replication by antisense phosphorothioate oligodeoxynucleotides in vitro and in vivo].
    Dong B; Shao XW; Tao PZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):25-7. PubMed ID: 12870012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of antisense DNA having C-5 polyamine substituted 2'-deoxyuridine derivative.
    Sakai H; Moriguchi T; Suzuki H; Matsukura M; Shinozuka K
    Nucleic Acids Res Suppl; 2001; (1):127-8. PubMed ID: 12836297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorothioate oligodeoxynucleotides: antisense or anti-protein?
    Krieg AM; Stein CA
    Antisense Res Dev; 1995; 5(4):241. PubMed ID: 8746772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.